Ubs Group Ag Sesen Bio, Inc. Transaction History

Ubs Group Ag

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.49 - $0.61 $24,498 - $30,498	-49,997 Reduced 82.99%	10,250 $6,000
Q3 2022 Nov 10, 2022	BUY	$0.0 - $0.93 $0 - $55,332	59,497 Added 7932.93%	60,247 $26,000
Q2 2022 Aug 10, 2022	SELL	$0.38 - $0.89 $21,250 - $49,770	-55,922 Reduced 98.68%	750 $1,000
Q1 2022 May 16, 2022	SELL	$0.58 - $0.86 $21,445 - $31,798	-36,975 Reduced 39.48%	56,672 $34,000
Q4 2021 Feb 14, 2022	BUY	$0.73 - $1.28 $67,084 - $117,628	91,897 Added 5251.26%	93,647 $76,000
Q3 2021 Nov 15, 2021	SELL	$0.77 - $4.91 $5,343 - $34,070	-6,939 Reduced 79.86%	1,750 $1,000
Q2 2021 Aug 13, 2021	BUY	$2.18 - $4.66 $12,947 - $27,675	5,939 Added 215.96%	8,689 $40,000
Q1 2021 May 12, 2021	BUY	$1.3 - $3.24 $1,651 - $4,114	1,270 Added 85.81%	2,750 $7,000
Q3 2020 Nov 12, 2020	SELL	$0.67 - $1.4 $20,381 - $42,588	-30,420 Reduced 95.36%	1,480 $2,000
Q2 2020 Jul 31, 2020	BUY	$0.52 - $0.87 $2,425 - $4,058	4,665 Added 17.13%	31,900 $23,000
Q1 2020 May 01, 2020	BUY	$0.39 - $1.03 $10,044 - $26,527	25,755 Added 1740.2%	27,235 $15,000
Q2 2019 Aug 14, 2019	SELL	$0.95 - $2.46 $10,376 - $26,870	-10,923 Reduced 88.07%	1,480 $2,000
Q1 2019 May 14, 2019	BUY	$0.69 - $1.47 $7,536 - $16,056	10,923 Added 738.04%	12,403 $13,000
Q4 2018 Feb 14, 2019	SELL	$0.96 - $2.04 $2,797 - $5,944	-2,914 Reduced 66.32%	1,480 $2,000
Q3 2018 Nov 14, 2018	BUY	$1.54 - $2.38 $6,766 - $10,457	4,394 New	4,394 $9,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.